Clinical and Molecular Investigations Into Ciliopathies
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00068224|
Recruitment Status : Completed
First Posted : September 10, 2003
Last Update Posted : February 21, 2021
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||374 participants|
|Official Title:||Clinical and Molecular Investigations Into Ciliopathies|
|Actual Study Start Date :||March 16, 2003|
|Actual Primary Completion Date :||October 16, 2019|
|Actual Study Completion Date :||February 18, 2021|
Children and adults who carry a clinical diagnosis of a known ciliopathy and those patients who have typical features suggestive of a cliopathy but not fulfilling the diagnostic criteria.
- Ciliopathy [ Time Frame: ongoing ]The general objective of this study is to assess the clinical characteristics of ciliopathies.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00068224
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Meral Gunay-Aygun, M.D.||National Human Genome Research Institute (NHGRI)|